ATE109349T1 - 3-substituierte-2-oxindolderivate als interleukin-biosynthesehemmer. - Google Patents
3-substituierte-2-oxindolderivate als interleukin-biosynthesehemmer.Info
- Publication number
- ATE109349T1 ATE109349T1 AT90310806T AT90310806T ATE109349T1 AT E109349 T1 ATE109349 T1 AT E109349T1 AT 90310806 T AT90310806 T AT 90310806T AT 90310806 T AT90310806 T AT 90310806T AT E109349 T1 ATE109349 T1 AT E109349T1
- Authority
- AT
- Austria
- Prior art keywords
- interleukin
- substituted
- biosynthesis inhibitors
- derivatives
- oxindol derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42144589A | 1989-10-13 | 1989-10-13 | |
US52905090A | 1990-05-25 | 1990-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE109349T1 true ATE109349T1 (de) | 1994-08-15 |
Family
ID=27025248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90310806T ATE109349T1 (de) | 1989-10-13 | 1990-10-03 | 3-substituierte-2-oxindolderivate als interleukin-biosynthesehemmer. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5192790A (de) |
EP (1) | EP0425109B1 (de) |
JP (1) | JPH0684300B2 (de) |
KR (1) | KR910007526A (de) |
AT (1) | ATE109349T1 (de) |
AU (1) | AU624739B2 (de) |
CA (1) | CA2027394C (de) |
DE (1) | DE69011272T2 (de) |
DK (1) | DK0425109T3 (de) |
HU (2) | HUT59004A (de) |
IE (1) | IE63140B1 (de) |
IL (1) | IL95880A (de) |
MY (1) | MY106834A (de) |
PT (1) | PT95566B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6266485B1 (en) | 1998-02-19 | 2001-07-24 | Emerson Electric Co. | One-piece plastic tank and temperature control system for a hot water dispenser |
JP2002525362A (ja) * | 1998-09-30 | 2002-08-13 | エスヴァイン、アンゲリカ | 代謝性骨障害の治療および予防のためのロダニンカルボン酸誘導体 |
US20020077276A1 (en) * | 1999-04-27 | 2002-06-20 | Fredeking Terry M. | Compositions and methods for treating hemorrhagic virus infections and other disorders |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
IN162090B (de) * | 1984-03-19 | 1988-03-26 | Pfizer | |
US4569942A (en) * | 1984-05-04 | 1986-02-11 | Pfizer Inc. | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
IN161509B (de) * | 1984-05-04 | 1987-12-19 | Pfizer | |
US4678802A (en) * | 1985-07-09 | 1987-07-07 | Pfizer Inc. | 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents |
GB8517958D0 (en) * | 1985-07-16 | 1985-08-21 | Cellena Cell Eng Ag | Compositions containing melatonin/homologues |
AU6898287A (en) * | 1986-01-30 | 1987-08-25 | University Of Utah, The | Treatment of bone loss |
US4677132A (en) * | 1986-03-12 | 1987-06-30 | American Home Products Corporation | Inhibition of bone resorption by etodolac |
US4861794A (en) * | 1988-04-13 | 1989-08-29 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis |
US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
-
1990
- 1990-10-02 IL IL9588090A patent/IL95880A/en not_active IP Right Cessation
- 1990-10-03 EP EP90310806A patent/EP0425109B1/de not_active Expired - Lifetime
- 1990-10-03 AT AT90310806T patent/ATE109349T1/de not_active IP Right Cessation
- 1990-10-03 DE DE69011272T patent/DE69011272T2/de not_active Expired - Fee Related
- 1990-10-03 DK DK90310806.6T patent/DK0425109T3/da active
- 1990-10-11 MY MYPI90001771A patent/MY106834A/en unknown
- 1990-10-11 PT PT95566A patent/PT95566B/pt not_active IP Right Cessation
- 1990-10-11 JP JP2273150A patent/JPH0684300B2/ja not_active Expired - Lifetime
- 1990-10-11 CA CA002027394A patent/CA2027394C/en not_active Expired - Fee Related
- 1990-10-12 HU HU906436A patent/HUT59004A/hu unknown
- 1990-10-12 AU AU64582/90A patent/AU624739B2/en not_active Ceased
- 1990-10-12 IE IE364890A patent/IE63140B1/en not_active IP Right Cessation
- 1990-10-12 KR KR1019900016153A patent/KR910007526A/ko not_active Application Discontinuation
-
1991
- 1991-12-17 US US07/808,491 patent/US5192790A/en not_active Expired - Fee Related
-
1995
- 1995-05-11 HU HU95P/P00128P patent/HU210902A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HU210902A9 (en) | 1995-09-28 |
EP0425109B1 (de) | 1994-08-03 |
IE903648A1 (en) | 1991-04-24 |
PT95566B (pt) | 1997-11-28 |
AU624739B2 (en) | 1992-06-18 |
CA2027394A1 (en) | 1991-04-14 |
DE69011272D1 (de) | 1994-09-08 |
AU6458290A (en) | 1991-04-18 |
DK0425109T3 (da) | 1994-11-21 |
EP0425109A3 (en) | 1992-01-15 |
HU906436D0 (en) | 1991-04-29 |
MY106834A (en) | 1995-07-31 |
KR910007526A (ko) | 1991-05-30 |
CA2027394C (en) | 1995-01-03 |
JPH03133929A (ja) | 1991-06-07 |
EP0425109A2 (de) | 1991-05-02 |
HUT59004A (en) | 1992-04-28 |
IE63140B1 (en) | 1995-03-22 |
PT95566A (pt) | 1991-08-14 |
US5192790A (en) | 1993-03-09 |
JPH0684300B2 (ja) | 1994-10-26 |
DE69011272T2 (de) | 1994-11-24 |
IL95880A (en) | 1995-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69435086D1 (de) | Phenylacetate und Derivate, allein oder in Kombination mit anderen Verbindungen, zur Behandlung von neoplastischen und anderen Erkrankungen | |
DK0513702T3 (da) | Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering | |
PL398445A1 (pl) | Kompozycje farmaceutyczne zawierające dekstrometorfan i chininę do leczenia zaburzeń neurologicznych | |
IL125282A (en) | Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases | |
DE58902712D1 (de) | N-acetylglucosamin-zubereitungen zur buccalen anwendung. | |
DE3480053D1 (en) | A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor | |
DK174389A (da) | Anvendelse af 3-substituerede 2-oxindol-1-carboxamid-forbindelser til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-biosyntese | |
IL111580A (en) | Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders | |
DE69011272D1 (de) | 3-Substituierte-2-Oxindolderivate als Interleukin-Biosynthesehemmer. | |
IT9020968A0 (it) | Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche | |
IT8467682A0 (it) | Composizione farmaceutica sinergistica per il trattamento di disturbi epatici contenente 4(5)-amminoimidazolo-5(4)carbossamide ortofosfato e vitamine | |
ATE208402T1 (de) | Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren | |
DK0608648T3 (da) | Højdoserede vitamin A-præparater | |
ATE136776T1 (de) | Verwendung von heptastigmin zur behandlung der zerebralen ictus | |
ITMI931174A0 (it) | Composizioni farmaceutiche per la cura della talassemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |